Lucidenic acid CCAS# 95311-96-9 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 95311-96-9 | SDF | Download SDF |
PubChem ID | 20056103 | Appearance | Powder |
Formula | C27H40O7 | M.Wt | 476.60 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (4R)-4-[(3S,5R,7S,10S,12S,13R,14R,17R)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | ||
SMILES | CC(CCC(=O)O)C1CC(=O)C2(C1(C(C(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)O)C)C | ||
Standard InChIKey | XIMQDJNNBMWDIH-YAQOJFSYSA-N | ||
Standard InChI | InChI=1S/C27H40O7/c1-13(7-8-19(31)32)14-11-18(30)27(6)20-15(28)12-16-24(2,3)17(29)9-10-25(16,4)21(20)22(33)23(34)26(14,27)5/h13-17,23,28-29,34H,7-12H2,1-6H3,(H,31,32)/t13-,14-,15+,16+,17+,23-,25+,26+,27+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Lucidenic acid C has anti-invasive effect, it shows significant inhibitory effects on PMA-induced MMP-9 activity and invasion of HepG(2 )cells. |
Targets | MMP(e.g.TIMP) |
Lucidenic acid C Dilution Calculator
Lucidenic acid C Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.0982 mL | 10.491 mL | 20.982 mL | 41.9639 mL | 52.4549 mL |
5 mM | 0.4196 mL | 2.0982 mL | 4.1964 mL | 8.3928 mL | 10.491 mL |
10 mM | 0.2098 mL | 1.0491 mL | 2.0982 mL | 4.1964 mL | 5.2455 mL |
50 mM | 0.042 mL | 0.2098 mL | 0.4196 mL | 0.8393 mL | 1.0491 mL |
100 mM | 0.021 mL | 0.1049 mL | 0.2098 mL | 0.4196 mL | 0.5245 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Lucidenic acid A
Catalog No.:BCN2715
CAS No.:95311-94-7
- Kajiichigoside F1
Catalog No.:BCN6433
CAS No.:95298-47-8
- Yadanzioside G
Catalog No.:BCN6716
CAS No.:95258-17-6
- Yadanzioside C
Catalog No.:BCN6717
CAS No.:95258-16-5
- Yadanzioside A
Catalog No.:BCN6718
CAS No.:95258-15-4
- Yadanziolide A
Catalog No.:BCN6721
CAS No.:95258-14-3
- Yadanziolide B
Catalog No.:BCN6720
CAS No.:95258-13-2
- Yadanziolide C
Catalog No.:BCN6719
CAS No.:95258-12-1
- Yadanzioside F
Catalog No.:BCN6406
CAS No.:95258-11-0
- Hydrangenoside A dimethyl acetal
Catalog No.:BCN4553
CAS No.:952485-00-6
- 11-Oxomogroside III
Catalog No.:BCN3169
CAS No.:952481-53-7
- Neocaesalpin L
Catalog No.:BCN7650
CAS No.:952473-86-8
- Ganoderic acid C1
Catalog No.:BCN3035
CAS No.:95311-97-0
- 2-Hydroxy-5-(2-hydroxy-4-methoxybenzyl)-4-methoxybenzaldehyde
Catalog No.:BCN7769
CAS No.:953427-66-2
- Hainanmurpanin
Catalog No.:BCN4503
CAS No.:95360-22-8
- BLZ945
Catalog No.:BCC5583
CAS No.:953769-46-5
- 15-Hydroxy-7-oxodehydroabietic acid
Catalog No.:BCN4504
CAS No.:95416-25-4
- Neotuberostemonone
Catalog No.:BCN4505
CAS No.:954379-68-1
- Hydroxytuberosone
Catalog No.:BCN4552
CAS No.:95456-43-2
- 5-Hydroxy-7-acetoxy-8-methoxyflavone
Catalog No.:BCN4506
CAS No.:95480-80-1
- 10Panx
Catalog No.:BCC1245
CAS No.:955091-53-9
- 8,3'-Diprenylapigenin
Catalog No.:BCN6482
CAS No.:955135-37-2
- MK-1775
Catalog No.:BCC2543
CAS No.:955365-80-7
- PI-3065
Catalog No.:BCC5379
CAS No.:955977-50-1
The anti-invasive effect of lucidenic acids isolated from a new Ganoderma lucidum strain.[Pubmed:17979098]
Mol Nutr Food Res. 2007 Dec;51(12):1472-7.
Ganoderma lucidum is a well-known mushroom with various pharmacological effects that has been used for health and longevity purposes. The objective of this study was to investigate the anti-invasive effect of lucidenic acids isolated from a new G. lucidum strain (YK-02) against human hepatoma carcinoma (HepG(2)) cells. Triterpenoid components in the ethanol extract of G. lucidum (YK-02) were separated by means of a semi-preparative RP HPLC. Four major peaks were separated and crystallized from triterpenoids fraction, and were identified as lucidenic acids A, B, C, and N according to their spectroscopic values of (1)H NMR and MS. Treatment of the lucidenic acids (50 microM) in the presence of 200 nM phorbol 12-myristate 13-acetate (PMA) after 24 h of incubation all resulted in significant inhibitory effects on PMA-induced MMP-9 activity and invasion of HepG(2 )cells. The results indicate that the lucidenic acids isolated from G. lucidum (YK-02) are anti-invasive bioactive components on hepatoma cells.
[Ganoderma triterpenoids from aqueous extract of Ganoderma lucidum].[Pubmed:29090550]
Zhongguo Zhong Yao Za Zhi. 2017 May;42(10):1908-1915.
A new triterpenoid and 18 analogues were isolated from the water extract of Ganoderma lucidum by column chromatographic techniques, including silica gel, ODS, Sephadex LH-20, and HPLC. The new compound was elucidated as 2beta-acetoxy-3beta,25-dihydroxy-7,11,15-trioxo-lanost-8-en-26-oic acid on the basis of analyses of extensive spectroscopic data and its physicochemical properties. Comparison of NMR data with those reported in literature, the known analogues were determined as ganoderic acid H (2), 12beta-acetoxy-3beta,7beta-dihydroxy-11,15,23-trioxo-lanost-8,16-dien-26-oic acid (3), ganoderenic acid D (4),ganoderic acid C1 (5),ganoderic acid G (6),3beta,7beta-dihydroxy-11,15,23-trioxo-lanost-8,16-dien-26-oic acid (7),ganoderic acid B (8),ganoderic acid C6 (9),3beta,15alpha-dihydroxy-7,11,23-trioxo-lanost-8,16-dien-26-oic acid (10),ganoderic acid A (11),ganolucidic acid A (12),lucidenic acid E2 (13),lucidenic acid N (14),lucidenic acid P (15), lucidenic acid B (16),lucidenic acid A (17),Lucidenic acid C (18),and lucidenic acid L (19), respectively. Compound 1 is new compound and compounds 2-19 have been reported from G. lucidum. The present study enriches the knowledge of the chemical constituent of G. lucidum and completes chemical investigation of water decoction that is traditional use of G. lucidum.
[A new triterpene from the fruiting bodies of Ganoderma lucidum].[Pubmed:12579936]
Yao Xue Xue Bao. 2001 Aug;36(8):595-8.
AIM: To study the chemical constituents of the fruiting bodies of Ganoderma lucidum. METHODS: Individual constituents, isolated and repeatedly purified on silica gel column, were identified by physicochemical constants and structurally elucidated by spectral methods. RESULTS: From the alcohol extract, compound 2 was obtained and identified as 3 beta,7 beta-dihydroxy-4,4,14 alpha-trimethyl-11,15-dioxo-5 alpha-chol-8-en-24-oic acid. In addition, two known compounds, lucidenic acid A (1) and C (3) were obtained. CONCLUSION: Compound 2 is a new triterpene compound.